Document ID: chunk:federal_register_of_legislation:F2024L01524:schedule:1:p8
Version: federal_register_of_legislation:F2024L01524
Segment Type: schedule
Provision Reference: sch 1 (pt 8/38)
Character Range: 20500–23779

(all instances): C10792 substitute (all instances): C16154
[55] Schedule 1, Part 1, omit entry for Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate 150 mg in 1 mL
[56] Schedule 1, Part 1, after entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg [Brand: Diaformin; Maximum Quantity: 200; Number of Repeats: 5]
insert:
Metformin  Tablet containing metformin hydrochloride 500 mg  Oral  Diaformin Viatris  MQ  MP NP             100  5     100
Metformin  Tablet containing metformin hydrochloride 500 mg  Oral  Diaformin Viatris  MQ  MP NP     P14238  200  5     100

[57] Schedule 1, Part 1, after entry for Metformin in the form Tablet containing metformin hydrochloride 1 g [Brand: Metformin Sandoz; Maximum Quantity: 180; Number of Repeats: 5]
insert:
Metformin  Tablet containing metformin hydrochloride 1 g  Oral  METFORMIN-WGR  WG  MP NP             90   5     90
Metformin  Tablet containing metformin hydrochloride 1 g  Oral  METFORMIN-WGR  WG  MP NP     P14238  180  5     90

[58] Schedule 1, Part 1, after entry for Methadone in the form Oral liquid containing methadone hydrochloride 25 mg per 5 mL in 200 mL bottle, 1 mL [Brand: Biodone Forte]
insert:
Methadone  Tablet containing methadone hydrochloride 10 mg  Oral  METHADONE-AFT  AE  MP NP  C15994 C15996 C16000  P15994 P15996 P16000  20   0  V15994 V15996 V16000  20
Methadone  Tablet containing methadone hydrochloride 10 mg  Oral  METHADONE-AFT  AE  MP NP  C11696                P11696                120  0  V11696                20

[59] Schedule 1, Part 1, entries for Methylphenidate in each of the forms: Capsule containing methylphenidate hydrochloride 10 mg (modified release); Capsule containing methylphenidate hydrochloride 20 mg (modified release); Capsule containing methylphenidate hydrochloride 30 mg (modified release); Capsule containing methylphenidate hydrochloride 40 mg (modified release); and Capsule containing methylphenidate hydrochloride 60 mg (modified release)
omit from the column headed "Circumstances" (all instances): C13922 substitute (all instances): C16152
[60] Schedule 1, Part 1, entries for Methylphenidate in each of the forms: Tablet containing methylphenidate hydrochloride 18 mg (extended release); Tablet containing methylphenidate hydrochloride 27 mg (extended release); Tablet containing methylphenidate hydrochloride 36 mg (extended release); and Tablet containing methylphenidate hydrochloride 54 mg (extended release)
omit from the column headed "Circumstances" (all instances): C10717 substitute (all instances): C16189
[61] Schedule 1, Part 1, entry for Molnupiravir
omit from the column headed "Circumstances": C15050 C15055 C15056 C15062 substitute: C16190 C16191 C16200 C16201
[62] Schedule 1, Part 1, entries for Nevirapine in the form Tablet 200 mg
omit:
Nevirapine  Tablet 200 mg  Oral  Nevirapine Alphapharm  AF  MP NP  C4454 C4512     120  5     60     D(100)

[63] Schedule 1, Part 1, entry for Nirmatrelvir and ritonavir
omit from the column headed "Circumstances": C13748 C13759 C13821 C15049 substitute: C16155 C16156 C16192 C16223
[64] Schedule 1, Part 1, entries for Nivolumab with relatlimab
substitute:
Nivolumab with relatlimab  Solution concentrate for I.V. infusion containing 240 mg